View More View Less
  • 1 ELTE Személyiség- és Egészségpszichológia Tanszék Budapest
  • | 2 ELTE Élettani és Neurobiológiai Tanszék Budapest
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $204.00

Áttekintésünk célja a nocebo-jelenség átfogó ismertetése, valamint három, a szakirodalomban rendszerint különállóként kezelt jelenségkör (nocebo, egészséges személyek tünetbeszámolója, orvosilag nem megmagyarázott panaszok) rövid összehasonlítása. Elméletünk szerint e jelenségek között a kiváltó és fenntartó mechanizmusok szintjén annyira szoros a rokonság, hogy tárgyalásuk egységes fogalmi keretben (nem-specifikus egészségproblémák) lenne indokolt.Ennek bizonyítására áttekintjük a jelenségek mögött álló potenciális pszichofiziológiai mechanizmusokat (az elvárások különböző típusai; klasszikus kondicionálás; társas tanulás; stressz, szorongás, depresszió; szomatizáció; a tabletták anyaga; valós betegségek tünetei) és motivációs hátteret (kontrolligény és hibás oktulajdonítás; gyógyszerek hatásosságának megítélése; terápiás rezisztencia; bűntudat és önbüntetés; tömegjelenségek; másodlagos betegségelőnyök; tudatos szimuláció), illetve a fontosabb kapcsolódó diszpozicionális személyiségjellemzőket (női nem; neuroticizmus; testi folyamatok fokozott észrevételére való hajlam).Röviden összehasonlítjuk a nocebo- és a placebo-jelenséget, és ellenezzük azt a megközelítést, ami a kettőt egymás tükörképének tekinti.Végül összefoglaljuk és kiegészítjük a korábbi irodalomban található, a nocebo-hatás csökkentését célzó intervenciós lehetőségeket.

  • Abramson , H. A., Jarvik , M. E., Levine , A., Kaufman , M. R., Hirsch , M. W. (1955) Lysergic Acid diethylamide (LSD-25): XV. The effects produced by substitution of a tap water placebo. The Journal of Psychology, 40, 367–383.

  • Ádám , Gy. (1998) Visceral perception: Understanding Internal Cognition . Plenum Press, New York

  • AlAbsi , M., Rokke , P. D. (1991) Can anxiety help us tolerate pain? Pain, 46, 43–51.

  • Andrykowski , M. A., Jacobsen , P. B., Marks , E., Gorfinkle , K., Hakes , T. B., Kaufman , R. J., Currie , V. E., Holland , J. C., Redd , W. H. (1988) Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer, 62, 2607–2613.

  • Andrykowski , M. A., Redd , W. H. (1987) Longitudinal Analysis of the Development of Anticipatory Nausea. Journal of Consulting and Clinical Psychology, 55, 36–41.

  • Avery , C. W., Ibelle , B. P., Allison , B., Mandell , N. (1967) Systematic errors in the evaluation of side effects. The American Journal of Psychiatry, 123, 875–878.

  • Bárdos , Gy ., Balassa , T., Elek , Sz ., Szemerszky , R., Polyák , Á. (2006) Animal models of non-specific health problems caused by low-frequency electromagnetic field exposure. FENS Abstracts, 3, A129.2.

  • BárdosGy . (2003) Viselkedés-élettan. I.: Pszichovegetatív kölcsönhatások . Scolar, Budapest

  • Bárdos , Gy ., Balassa , T., Szemerszky , R., Polyák , Á. (2007) Non-specific effects of electro-magnetic fields: Animal models? Clinical Neuroscience, 60 (S1), 9–10.

  • Barefoot , J. C., Girodo , M. (1972) The misattribution of smoking cessation symptoms. Canad. Journal Behav. Sci./Rev. Canad. Sci. Comp., 4 (4), 358–363.

  • Barsky , A. J. (1979) Patients who amplify bodily sensations. Annals of Internal Medicine, 91, 63–70.

  • Barsky , A. J. (1983) Nonpharmacologic aspects of medication. Archives of Internal Medicine, 143, 1544–1548.

  • Barsky , A. J., Borus , J. F. (1999) Functional Somatic Syndromes. Annals of Internal Medicine, 130, 910–921.

  • Barsky , A. J., Goodson , J. D., Lane , R. S., Cleary , P. D. (1988) The amplification of somatic symptoms. Psychosomatic Medicine, 50, 510–519.

  • Barsky , A. J., Rogers , M. P., Borus , J. F. (2002) When are medication side effects due to the nocebo phenomenon? Reply. Journal of the American Medical Association, 287 (19), 2503–2504.

  • Barsky , A. J., Saintfort , R., Rogers , M. P., Borus , J. (2002) Nonspecific medication side effects and the nocebo phenomenon. Journal of the American Medical Association, 287 (5), 622–627.

  • Barsky , A. J., Saintfort , R., Rogers , M. P., Borus , J. F. (2004) Nonspecific medication side effects and the nocebo phenomenon. Science and Engineering Ethics, 10, 133–134.

  • Beecher , H. K. (1955) The powerful placebo. Journal of the American Medical Association, 159, 1602–1606.

  • Benedetti , F., Amanzio , M. (1997) The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Progress in Neurobiology, 51, 109–125.

  • Benedetti , F., Amanzio , M., Casadio , C., Oliaro , A., Maggi , G. (1997) Blockade of nocebo hyperalgesia by cholecystokinin antagonist proglumide. Pain, 71, 135–140.

  • Benedetti , F., Amanzio , M., Vighetti , S., Asteggiano , G. (2006) The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect. The Journal of Neuroscience, 26, 12014–12022.

  • Benedetti , F., Lanotte , M., Lopiano , L., Colloca , L. (2007) When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience, 147, 260–271.

  • Benedetti , F., Pollo , A., Lopiano , L., Lanotte , M., Vighetti , S., Rainero , I. (2003) Conscious expectation and unconscious conditioning in analgesic; motor and hormonal placebo/nocebo responses. The Journal of Neuroscience, 23, 4315–4323.

  • Benson , H. (1997) The nocebo effect: history and physiology. Preventive Medicine, 26, 612–615.

  • Berthelot , J.-M., Maugars , Y., Abgrall , M., Prost , A. (2001) Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine, 68, 65–70.

  • Blackwell , B., Bloomfield , S. S., Buncher , C. R. (1972) Demonstration to medical students of placebo responses and non-drug factors. Lancet, 763 (1), 1279–1282.

  • Bootzin , R. R., Baile Y, E. T. (2005) Understanding Placebo, Nocebo, and Iatrogenic Treatment Effects. Journal of Clinical Psychology, 61, 871–880.

  • Bradley , G. W. (1978) Self-Serving Biases in the Attribution Process: A Reexamination of the Fact or Fiction Question. Journal of Personality and Social Psychology, 36 (1), 56–71.

  • Brody , H. (2000) The placebo response . Harper Collins, New York

  • Brown , R. J. (2006) Medically unexplained symptoms: a new model. Psychiatry, 5, 43–47.

  • Brown , R. S., Lees -Haley , P. R. (1992) Fear of future illness, chemical aids, and cancerophobia: a review. Psychological Reports, 71, 187–207.

  • Buss , A. H. (1980) Self-consciousness and social anxiety . W. H. Freeman & Co, San Francisco

  • Butler , C., Steptoe , A. (1986) Placebo Responses: An Experimental Study of Psychophysiological Processes in Asthmatic Volunteers. British Journal of Clinical Psychology, 25, 173–183.

  • Carver , C., Scheier , M. (1981) Attention and self-regulation . Springer, New York

  • Casper , R. C., Tollefson , G. D., Nilsson , M. E. (2001) No Gender Differences in Placebo Responses of Patients with Major Depressive Disorder. Biological Psychiatry, 49, 158–160.

  • Cioffi , D. (1991) Beyond attentional strategies: a cognitive-perceptual model of somatic interpretation. Psychological Bulletin, 109, 25–41.

  • Cluff , L. E., Thornton , G. F., Seidl , L. G. (1964) Studies on the epidemiology of adverse drug reactions. Journal of the American Medical Association, 188, 976–983.

  • Colloca , L., Benedetti , F. (2007) Nocebo hyperalgesia: how anxiety is turned into pain. Current Opinion in Anaesthesiology, 20, 435–439.

  • Colloca , L., Vighetti , S., Sigaudo , M., Benedetti , F. (2007) Hyperalgesic and allodynic effects of nocebo suggestions. European Journal of Pain, 11 (S1), S59–S20.

  • Costa , P. T., McCrae , R. R. (1987) Neuroticism, somatic complaints, and disease: is the bark worse than the bite? Journal of Personality, 55, 299–316.

  • Cox , T., Thirlawa Y, M., Gotts , G., Cox , S. (1983) The nature and assessment of general well-being. Journal of Psychosomatic Research, 27, 353–359.

  • Dahan , R., Caulin , C., Figea , L., Kanis , J. A., Caulin , F., Segrestaa , J. M. (1986) Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admitted to hospital. British Medical Journal, 293, 363–364.

  • Davis , C., Ralevski , E., Kennedy , S. H., Neitzert , C. (1967) The role of personality factors in the reporting of side effect complaints to moclobemide and placebo. Journal of Consulting and Clinical Psychology, 31, 71–76.

  • Davis , C., Ralevski , E., Kennedy , S. H., Neitzert , C. (1995) The Role of Personality Factors in the Reporting of Side Effect Complaints to Moclobemide and Placebo: A Study of Healthy Male and Female Volunteers. Journal of Clinical Psychopharmacology, 15 (5), 347–352.

  • DeCharms , R. (1968) Personal causation: The internal affective determinants of behavior . Academic Press, New York

  • Dhume , V. G., Agshikar , N. V., Diniz , R. S. (1975) Placebo-induced side-effects in healthy volunteers. Clinician, 39, 289–290.

  • Diehl , H. S. (1933) Medical treatment of the common cold. Journal of the American Medical Association, 101, 2042–2049.

  • Downing , R. W., Rickels , K. (1967) Self-report of hostility and the incidence of side reactions in neurotic outpatients treated with tranquilizing drugs and placebo. Journal of Consulting Psychology, 31 (1), 71–76.

  • Drici , M. D., Raybaud , F., DeLunardo , C., Iacono , P., Gustovic , P. (1995) Influence of the behavior pattern on the nocebo response of healthy volunteers. British Journal of Clinical Pharmacology, 39, 204–206.

  • Duncan , J. W., Laird , J. D. (1980) Positive and Reverse Placebo Effects as a Function of Differences in Cues Used in Self-Perception. Journal of Personality and Social Psychology, 39 (6), 1024–1036.

  • Eikelboom , R., Stewart , J. (1982) Conditioning of drug-induced physiological responses. Psychological Review, 89, 507–528.

  • Engel , Jr . C. C., Adkins , J. A., Cowan , D. N. (2002) Caring for medically unexplained physical symptoms after toxic environmental exposures: effects of contested causation. Environmental Health Perspectives, 10 (Suppl 4), 641–647.

  • Evans , R. W. (2003) The Non-nocebo Response: Can Migraine Medication Efficacy Be Enhanced? Headache: The Journal of Head and Face Pain, 43, 693.

  • Evans , R. W., Rogers , M. P. (2003) Headaches and the Nocebo Effect. Headache, 43, 1113–1115.

  • Ferguson , J. M. (1993) Alprazolam XR: patient acceptability, safety, and tolerability. Psychiatric Annals, 23, 20–26.

  • Fisher , S., Fisher , R. L. (1963) Placebo response and acquiescence. Psychopharmacologia, 4, 298–301.

  • Flaten , M. A., Simonsen , T., Olsen , H. (1999) Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosomatic Medicine, 61, 250–255.

  • Flaten , M. A., Simonsen , T., Waterloo , K., Olsen , H. (1997) Pharmacological classical conditioning in humans. Human Psychopharmacology – Clinical and Experimental, 12 (4), 369–377.

  • Geers , A. L., Helfer , S. G., Kosbab , K., Weiland , P., Landry , S. J. (2005) Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response. Journal of Psychosomatic Research, 58, 121–127.

  • Geers , A. L., Helfer , S. G., Weiland , P., Kosbab , K. (2006) Expectations and Placebo Response: A Laboratory Investigation into the Role of Somatic Focus. Journal of Behavioral Medicine, 29 (2), 171–178.

  • Geers , A. L., Weiland , P. E., Kosbab , K., Landry , S. J., Helfer , S. G. (2005) Goal activation, expectations, and the placebo effect. Journal of Personality and Social Psychology, 89, 143–159.

  • Glaser , E. M. (1953) Experiments on the side effects of drugs. British Journal of Pharmacology, 8, 187–192.

  • Glaser , E. M., Whittow , G. C. (1953) Evidence for a non-specific mechanism of habituation. Journal of Physiology, 122, 43P–44P.

  • Gliedman , L. H., Gantt , H. W., Teitelbaum , H. A. (1957) Some implications of conditional reflex studies for placebo research. American Journal of Psychiatry, 113, 1103–1107.

  • Golomb , B. A. (1995) Paradox of placebo effect. Nature, 375, 530.

  • Golomb , B. A. (1996) Using placebos. Nature, 379, 765.

  • Golomb , B. A. (2002) When are medication side effects due to the nocebo phenomenon? Letter to the editor. Journal of the American Medical Association, 287 (19), 2502–2503.

  • Gowdey , C. W., Hamilton , J. T., Philp , R. B. (1967) A controlled clinical trial using placebos in normal subjects: a teaching exercise. Canadian Medical Association Journal, 96, 1317–1322.

  • Green , D. M. (1962) Side effects. Federation Proceedings, 21, 179.

  • Green , D. M. (1964) Pre-existing conditions, placebo reactions, and “side effects.” Annals of Internal Medicine, 60, 255–265.

  • Greiner , T., Gold , H., Cattel , M., Travel , J., Bakst , H., Rinzler , S. H. et al. (1950) A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort. The American Journal of Medicine, 9, 143–155.

  • Hankoff , L. D., Freedman , N., Engelhardt , D. M. (1960) Placebo responses in schizophrenic outpatients. Archives of General Psychiatry, 2, 33–42.

  • Hebb , A. L. O., Poulin , J.-F., Roach , S. P., Zacharko , R. M., Drolet , G. (2005) Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 1225–1238.

  • Heider , F. (1958) The psychology of interpersonal relations . Wiley, New York

  • Honigfeld , G. (1964) Non-specific factors in treatment. I. Review of placebo reactions and placebo reactors. Diseases of the Nervous System, 25, 145–155.

  • Howland , J. S., Baker , M. G., Poe , T. (1990) Does patient education cause side effects? Controlled trial. Journal of Family Practice, 31, 62–64.

  • Jensen , M. P., Karoly , P. (1991) Motivation and Expectancy Factors in Symptom Perception: A Laboratory Study of the Placebo Effect. Psychosomatic Medicine, 53, 144–152.

  • Jewett , D. L., Fein , G., Greenberg , M. H. (1990) A double-blind study of symptom provocation to determine food sensitivity. The New England Journal of Medicine, 323, 429–433.

  • Kast , E. C., Loesch , J. (1961) Influence of the doctor-patient relationship on drug action. Illinois Medical Journal, 119, 390–393.

  • Keeley , R. (2002) When are medication side effects due to the nocebo phenomenon? Letter to the editor. Journal of the American Medical Association, 287 (19), 2503.

  • Kelley , H. H. (1973) The processes of causal attribution. American Psychologist, 28, 107–128.

  • Kennedy , W. P. (1961) The nocebo reaction. Medical World, 1961, 203–205.

  • Keown , C., Slovic , P., Lichtenstein , S. (1984) Attitudes of physicians, pharmacists and laypersons towards seriousness and need for disclosure of prescription drug side-effects. Health Psychology, 3, 1–11.

  • Kirsch , I. (1985) Response expectancy as a determinant of experience and behavior. American Psychologist, 40, 1189–1202.

  • Kirsch , I. (1997) Specifying Nonspecifics: Psychological Mechanisms of Placebo Effects. In Harrington , A. (ed.) The placebo effect. An interdisciplinary exploration . 166–186. Harvard University Press, Cambridge

  • Knowles , J. B., Lucas , C. J. (1960) Experimental studies of the placebo response. Journal of Mental Science, 106, 231–240.

  • Köteles F., BárdosGy . (2007) Tabletták várt hatása és színe/mérete közötti kapcsolatok. Mentálhigiéné és Pszichoszomatika, 8 (4), 277–290.

  • Köteles F., BárdosGy . (2008a) Placebo és személyiség – a primitívtől a megküzdőig. I. A placebo-reszponder személyiség. Pszichológia, 28 (3), 267–285.

  • Köteles F., BárdosGy . (2008b) Placebo és személyiség – a primitívtől a megküzdőig. II. Szituáció, emóció, motiváció, attribúció és megküzdés. Pszichológia, 28 (4), 339–356.

  • Köteles F., BárdosGy . (2009) Tabletták perceptuális jellemzői által generált mellékhatás-elvárások és pszichológiai hátterük. Mentálhigiéné és Pszichoszomatika, 10 (1), 47–62.

  • Köteles F., Fodor D., Cziboly Á., BárdosGy . (2007) A placebo terápiás felhasználásának etikai kérdései. Magyar Pszichológiai Szemle, 62 (4), 429–448.

  • Kradin , R. (2004) The placebo response – its putative role as a functional salutogenic mechanism of the central nervous system. Perspectives in Biology and Medicine, 47, 328–338.

  • Kradin , R. (2008) The placebo response and the power of unconscious healing . Routledge, New York–London

  • KulcsárZs ., Rózsa S., KökönyeiGy ., szerk. (2004) Megmagyarázhatatlan testi tünetek. Szomatizáció és funkcionális stresszbetegségek. I–II. ELTE Eötvös Kiadó, Budapest

  • Kunda , Z. (1990) The case for motivated reasoning. Psychological Bulletin, 108, 480–498.

  • Lang , E. V., Hatsiopoulou , O., Koch , T., Berbaum , K., Lutgendorf , S., Kettenmann , E., Logan , H., Kaptchuk , T. J. (2005) Can words hurt? Patient-provider interactions during invasive procedures. Pain, 114, 303–309.

  • Lasagna , L., Mosteller , F., von Felsinger , J. M., Beecher , H. K. (1954) A study of the placebo response. American Journal of Medicine, 16, 770–779.

  • Lees -Haley , P. R., Brown , R. S. (1992) Biases in perception and reporting following a perceived toxic exposure. Perceptual and Motor Skills, 75, 531–544.

  • Levine , R. J. (1987) The apparent incompatibility between informed consent and placebo-controlled clinical trials. Clinical Pharmacology and Therapeutics, 42, 247–249.

  • Linton , H. B., Langs , R. J. (1962) Placebo reactions in a study of lysergic acid diethylamide. Archives of General Psychiatry, 6, 369–383.

  • Lipowski , Z. J. (1988) Somatization: the concept and its clinical application. American Journal of Psychiatry, 145, 1358–1368.

  • Loftus , E. F., Fries , J. F. (1979) Informed consent may be hazardous to health. Science, 204, 11.

  • Maslow , A. H. (1970) Motivation and personality . Harper and Row, New York

  • McNair , D. M., Gardos , G., Haskell , D.S., Fisher , S. (1979) Placebo response, placebo effect, and two attributes. Psychopharmacology, 63, 245–250.

  • Mechanic , D. (1972) Social psychological factors affecting the presentation of bodily complaints. New England Journal of Medicine, 286, 1132–1139.

  • Miller , D. T. (1978) What Constitutes a Self-Serving Attributional Bias? A Reply to Bradley. Journal of Personality and Social Psychology, 36 (11), 1221–1223.

  • Miller , D. T., Ross , M. (1975) Self-serving biases in the attribution of casuality: fact or fiction? Psychological Bulletin, 52, 213–225.

  • Mintz , D. (2002) Meaning and medication in the care of treatment-resistant patients. American Journal of Psychoterapy, 56, 322–337.

  • Morselli , P. L., Garattini , S. (1970) Monosodium glutamate and the chinese restaurant syndrome. Nature, 227, 611–612.

  • Myers , M. G., Cairns , J. A., Singer , J. (1987) The consent form as a possible cause of side effects. Clinical Pharmacology and Therapeutics, 42, 250–253.

  • Olshansky , B. (2007) Placebo and Nocebo in Cardiovascular Health. Journal of the American College of Cardiology, 49, 415–421.

  • Pennebaker , J. W., Burnam , M. A., Schaeffer , M. A., Harper , D. C. (1977) Lack of Control as a Determinant of Perceived Physical Symptoms. Journal of Personality and Social Psychology, 35 (3), 167–174.

  • Pennebaker , J. W., Lightner , J. M. (1980) Competition of internal and external information in an exercise setting. Journal of Personality and Social Psychology, 39, 165–174.

  • Pennebaker , J. W., Skelton , J. (1981) Selective monitoring of bodily sensations. Journal of Personality and Social Psychology, 41, 213–223.

  • Pennebaker , J. W. (1982) The psychology of Physical Symptoms . Springer, New York

  • Pennebaker , J. W. (1994) Psychological bases of symptom reporting – perceptual and emotional aspects of chemical-sensitivity. Toxicology and Industrial Health, 10 (4–5), 497–511.

  • Pilling J. (2004) Rossz hírek közlése. In Pilling J. (szerk.) Orvosi kommunikáció . 391–412. Medicina, Budapest

  • Pogge , R. C. (1963) The toxic placebo. Part I – Side and toxic effects reported during the administration of placebo medicine. Medical Times, 91 (8), 1–6.

  • Preston , R. A., Barry , J. M., Reda , D. J., Williams , D. W. (2000) Placebo-Associated Blood Pressure Response and Adverse Effects in the Treatment of Hypertension. Archives of Internal Medicine, 160, 1449–1454.

  • Reeves , R. R., Ladner , M. E., Hart , R. H., Burke , R. S. (2007) Nocebo effects with antidepressant clinical drug trial placebos. General Hospital Psychiatry, 29, 275–277.

  • Reidenberg , M. M., Lowenthal , D. T. (1968) Adverse nondrug reactions. The New England Journal of Medicine, 279, 678–679.

  • Rickels , K. (1965) Some comments on non-drug factors in psychiatric therapy. Psychosomatics, 6, 303–309.

  • Rickels , K., Downing , R. (1967) Drug- and placebo-treated neurotic outpatients. Archives of General Psychiatry, 16, 369–372.

  • Rolle -Kampczyk , U., Diez , U. (2003) Impairment of health through mould and mildew exposure in the home. Tagliche praxis, 44, 211–219.

  • Rosenzweig , P., Brohier , S., Zipfel , A. (1993) The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies. Clinical Pharmacology and Therapeutics, 54 (5), 578–583.

  • Ross , M., Olson , J. M. (1981) An expectancy-attribution model of the effects of placebos. Psychological Review, 88, 408–437.

  • Schachter , S., Singer , J. (1962) Cognitive, social and physiological determinants of emotional state. Psychological Review, 69, 379–399.

  • Schweiger , A., Parducci , A. (1981) Nocebo: the psychologic induction of pain. The Pavlovian Journal of Biological Science, 16 (3), 140–143.

  • Shapiro , A. K., Mike , V., Barten , H., Shapiro , E. (1973) Study of the placebo effect with a self-administered placebo test. Comprehensive Psychiatry, 14, 535–548.

  • Shapiro , A. K., Shapiro , E. (1997) Summary and conclusions. In Shapiro , A. K., Shapiro , E. (eds) The powerful placebo . 228–237. The John Hopkins University Press, Baltimore–London

  • Shapiro , A. K., Struening , E. L., Shapiro , E. (1980) The reliability and validity of a placebo test. Journal of Psychiatric Research, 15, 253–290.

  • Shapiro , A. K., Wilensky , H., Struening , E. L. (1968) Study of the placebo effect with a placebo test. Comprehensive Psychiatry, 9, 118–137.

  • Shea , S. C. (2006) Improving medication adherence . Lippincott Williams & Wilkins, Philadelphia

  • Siegel , S. (1999) Multiple chemical sensitivity as a conditional response. Toxicology and Industrial Health, 15 (3–4), 323–330.

  • Siegel , S., Baptista , M. A. S., Kim , J. A., McDonald , R. V., Weise -Kelly , L. (2000). Pavlovian psychopharmacology: The associative basis of tolerance. Experimental and Clinical Psychopharmacology, 27, 125–136.

  • Siegel , S., Kreutzer , R. (1997) Pavlovian conditioning and multiple chemical sensitivity. Environmental Health Perspectives, 105 (Suppl. 2.), 521–526.

  • Sigaudo , M., Vighetti , S., Benedetti , F., Colloca , L. (2007) The nocebo effect: How stress modulates pain. European Psychiatry, 22, S270.

  • Smith , S., Henderson , M. (2000) What you don't know won't hurt you. Information given to patients about the side-effects of antipsychotic drugs. Psychiatric Bulletin, 24, 172–174.

  • Spiegel , H. (1997) Nocebo: the power of suggestibility. Preventive Medicine, 26, 616–621.

  • Spriet , A., Spriet , C., Larousse , C., Chigot , D., Roux , M., Simon , P. (1977) Methodology and results of a survey of adverse reactions to a drug in private practice. European Journal of Clinical Pharmacology, 11, 181–192.

  • Spurgeon , A., Gompertz , D., Harrington , J. M. (1996) Modifiers of non-specific symptoms in occuptaional and environmental syndromes. Occupational and Environmental Medicine, 53, 361–366.

  • Staats , P. S., Staats , A., Hekmat , H. (2001) The Additive Impact of Anxiety and a Placebo on Pain. Pain Medicine, 2, 267–279.

  • Ströhle , A. (2000) Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. Journal of Psychiatric Research, 34, 439–442.

  • Surtees , S. J., Stockton , M. G., Gietzen , T. W. (1991) Allergy to penicillin: fable or fact? British Medical Journal, 302, 1051–1052.

  • Szegedi , V., Bárdos , Gy ., Détári , L., Tóth , A., Banczerowski -Pelyhe , I., Világi , I. (2005) Transient alterations in neuronal and behavioral activity following bensultap and fipronil treatments of rats. Toxicology, 214, 67–76.

  • Szondy M. (2006) Optimizmus és egészség. Magyar Pszichológiai Szemle, 61 (4), 617–636.

  • Tangrea , J. A., Adrianza , M. E., Helsel , W. E. (1994) Risk factors for the development of placebo adverse reactions in a multicenter clinical trial. Annals of Epidemiology, 4 (4), 327–331.

  • The Treatment of Mild Hypertension Group (1991) The treatment of mild hypertension study. Archives of Internal Medicine, 151, 1413–1423.

  • Thompson , W. G. (2005) Placebo effect and health: Combining science with compassionate care . Prometheus Books, Amherst, MA

  • Thomson , R. (1982) Side effects and placebo amplification. British Journal of Psychiatry, 140, 64–68.

  • ThuróczyGy . (2002) A rádiófrekvenciás sugárzások egészségügyi kérdései. Magyar Tudomány, 8, 1010.

  • Uhlenhuth , E., Alexander , P. E., Dempsey , G. M., Jones , W., Coleman , B. S., Swiontek , A. M. (1998) Medication side effects in anxious patients: Negative placebo responses? Journal of Affective Disorders, 47, 183–190.

  • Ursin , H. (1997) Sensitization, Somatization, and Subjective Health Complaints. International Journal of Behavioral Medicine, 4, 105–116.

  • Varga K. (2006) Placebó és szuggesztió – a gyógyítás szolgálatában. Magyar Pszichológiai Szemle, 61 (4), 597–616.

  • Weary , G. (1979) Self-Serving Attributional Biases: Perceptual or Response Distortions? Journal of Personality and Social Psychology, 37 (8), 1418–1420.

  • White , R. W. (1959) Motivation reconsidered. The concept of competence. Psychological Review, 66, 297–333.

  • Whitehead , W. E., Busch , C. M., Heller , B. R., Costa , P. T. Jr . (1986) Social learning influences on menstrual symptoms and illness behavior. Health Psychology, 5, 13–23.

  • Whitehead , W. E., Fedoravicius , A. S., Blackwell , B., Wooley , S. (1979) A behavioral conceptualization of psychosomatic illness: Psychosomatic symptoms as learned responses. In McNamara , J. R. (ed.) Behavioral Approaches in Medicine: Application and Analysis . 65–99. Plenum Press, New York

  • Whitehorn , J. C. (1958) Psychiatric implications of the “placebo effect.” American Journal of Psychiatry, 114, 662–664.

  • Willer , J. C., Dehen , H., Cambier , J. (1981) Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science, 212, 689–691.

  • Williams , C. W., Lees -Haley , P. R., Price , J. R. (1998) Self-Attention and Reported Symptoms: Implications for Forensic Assessment. Professional Psychology: Research and Practice, 29 (2), 125–129.

  • Wolf , S. (1950) Effects of suggestion and conditioning on the action of chemical agents in human subjects – the pharmacology of placebos. Journal of Clinical Investigation, 29, 100–109.

  • Wolf , S., Pinsky , R. H. (1954) Effects of placebo administration and occurrence of toxic reactions. Journal of the American Medical Association, 155, 339.

 

The author instruction is available in PDF.
Please, download the file from HERE.

 

 

Senior editors

Editor(s)-in-Chief: Fülöp, Márta

Chair of the Editorial Board:
Molnár, Márk

          Area Editors

  • Bereczkei Tamás (Evolutionary psychology)
  • Demetrovics Zsolt (Clinical psychology)
  • Egyed Katalin (Developmental psychology)
  • Hámori Eszter (Clinical child psychology)
  • Molnárné Kovács Judit (Social psychology)
  • Rózsa Sándor (Personality psychology and psychometrics)
  • Nguyen Luu Lan Anh (Cross-cultural psychology)
  • Pléh Csaba (Book Review)
  • Sass Judit (Industrial and organizational psychology)
  • Szabó Éva (Educational psychology)
  • Urbán Róbert (Health psychology)
  • Csákvári Judit (Psychology of special education)
  • Faragó Klára (Organizational psychology)
  • Kéri Szabolcs (Experimental and Neuropsychology)

 

        Editorial Board

  • Császár Noémi
  • Csépe Valéria
  • Dúll Andrea
  • Ehmann Bea
  • Erős Ferenc
  • Gervai Judit
  • Kiss Enikő Csilla
  • Kiss Paszkál
  • Mészáros Judit
  • Németh Dezső
  • Oláh Attila
  • Péley Bernadette
  • Perczel-Forintos Dóra
  • Révész György
  • Winkler István
  • Molnár Márk
  • Fülöp Márta

 

Secretary of the editorial board: 

  •  Saád Judit

 

Magyar Pszichológiai Szemle
ELTE PPK Pszichológiai Intézet
Address: H-1064 Budapest, Izabella u. 46.
E-mail: pszichoszemle@gmail.com

Indexing and Abstracting Services:

  • PsycINFO
  • Scopus

2020  
Scimago
H-index
7
Scimago
Journal Rank
0,142
Scimago
Quartile Score
Psychology (miscellaneous) Q4
Scopus
Cite Score
17/111=0,2
Scopus
Cite Score Rank
General Psychology 199/203 (Q4)
Scopus
SNIP
0,079
Scopus
Cites
53
Scopus
Documents
24
Days from submission to acceptance 116
Days from acceptance to publication 225
Acceptance
Rate
81%

 

2019  
Scimago
H-index
6
Scimago
Journal Rank
0,139
Scimago
Quartile Score
Psychology (miscellaneous) Q4
Scopus
Cite Score
24/103=0,2
Scopus
Cite Score Rank
General Psychology 192/204 (Q4)
Scopus
SNIP
0,113
Scopus
Cites
35
Scopus
Documents
14
Acceptance
Rate
58%

 

Magyar Pszichológiai Szemle
Publication Model Hybrid
Submission Fee none
Article Processing Charge 900 EUR/article
Printed Color Illustrations 40 EUR (or 10 000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 152 EUR / 216 USD
Print + online subscription: 184 EUR / 244 USD
Subscription fee 2022 Online subsscription: 156 EUR / 220 USD
Print + online subscription: 188 EUR / 250 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Magyar Pszichológiai Szemle
Language Hungarian
Size B5
Year of
Foundation
1928
Publication
Programme
2021 Volume 76
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Pszichológiai Társaság 
Founder's
Address
H-1075 Budapest, Hungary Kazinczy u. 23-27. I/116. 
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0025-0279 (Print)
ISSN 1588-2799 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 5 0 0
May 2021 11 1 1
Jun 2021 4 0 0
Jul 2021 7 0 0
Aug 2021 2 0 0
Sep 2021 2 0 0
Oct 2021 0 0 0